Exogenous tumor necrosis factor alpha and interleukin-1 alpha increase resistance to Salmonella typhimurium: efficacy is influenced by the Ity and Lps loci

Infect Immun. 1995 Aug;63(8):3196-8. doi: 10.1128/iai.63.8.3196-3198.1995.

Abstract

Interleukin-1 alpha (IL-1 alpha) or tumor necrosis factor alpha (TNF-alpha) administered prior to infection with Salmonella typhimurium increases survival in mice that are Ityr, not in susceptible Lpsd or Itys mice. Combined IL-1 alpha and TNF-alpha pretreatment results in greater survival than that seen with either cytokine alone in Ityr mice. Treatment after infection with TNF-alpha and/or IL-1 alpha increases the mean time to death but not the survival fraction of Lpsd mice and was ineffective in either Ityr or Itys mice.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Female
  • Interleukin-1 / pharmacology*
  • Macrophages / immunology
  • Mice
  • Mice, Inbred A
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Salmonella Infections, Animal / genetics*
  • Salmonella Infections, Animal / immunology
  • Salmonella typhimurium / immunology
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Interleukin-1
  • Tumor Necrosis Factor-alpha